Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).

@article{Manchikanti2010ProtocolFA,
  title={Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).},
  author={Laxmaiah Manchikanti and Yogesh Malla and Bradley W. Wargo and Kimberly A. Cash and Vidyasagar Pampati and Kim S. Damron and Carla D. McManus and Doris E. Brandon},
  journal={Pain physician},
  year={2010},
  volume={13 1},
  pages={E1-E22}
}
BACKGROUND Therapeutic use, overuse, abuse, and diversion of controlled substances in managing chronic non-cancer pain continues to be an issue for physicians and patients. It has been stated that physicians, along with the public and federal, state, and local government; professional associations; and pharmaceutical companies all share responsibility for preventing abuse of controlled prescription drugs. The challenge is to eliminate or significantly curtail abuse of controlled prescription… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-8 of 8 references

Under the counter. The diversion and abuse of controlled prescription drugs in the U.S

LC Bollinger, C Bush, +18 authors MA. Wiener
The National Center on Addition and Substance Abuse at Columbia University (CASA), • 2005

Similar Papers

Loading similar papers…